Details for New Drug Application (NDA): 074732
✉ Email this page to a colleague
NDA 074732 describes TAMOXIFEN CITRATE, which is a drug marketed by Actavis Labs Fl Inc, Aegis Pharms, Apotex, Dr Reddys Labs Sa, Eugia Pharma, Ivax Sub Teva Pharms, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms, and is included in twelve NDAs. It is available from nine suppliers. Additional details are available on the TAMOXIFEN CITRATE profile page.
The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
Summary for 074732
| Tradename: | TAMOXIFEN CITRATE |
| Applicant: | Mylan |
| Ingredient: | tamoxifen citrate |
| Patents: | 0 |
Pharmacology for NDA: 074732
| Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 074732
Suppliers and Packaging for NDA: 074732
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 074732 | ANDA | Mylan Pharmaceuticals Inc. | 0378-0144 | 0378-0144-91 | 60 TABLET in 1 BOTTLE (0378-0144-91) |
| TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 074732 | ANDA | Mylan Pharmaceuticals Inc. | 0378-0274 | 0378-0274-93 | 30 TABLET in 1 BOTTLE (0378-0274-93) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
| Approval Date: | Feb 20, 2003 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Feb 20, 2003 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
